Bhaktivedanta Hospital & Research Institute

Recent papers from Bhaktivedanta Hospital & Research Institute

1. Autoimmune Lymphoproliferative Syndrome (ALPS) in Indian Population: Clinical, and Immunological Diversity in Genes Related to FAS-Mediated Apoptotic PathwayJournal of Clinical Immunology · 2026
2. Safety and Efficacy of Low Dose (7.5 mg) as Compared to Standard Dose (15 mg) Pioglitazone in Type 2 Diabetes and Metabolic Syndrome: A Systematic Review and Meta-analysisAnnals of African Medicine · 2026
3. Translating Guidelines into Practice: Implementation of NT-proBNP Testing for Early Heart Failure Detection in Diabetes, a Narrative ReviewJournal of General Internal Medicine · 2026
4. Expert Consensus on the Clinical Use of the Dapagliflozin–Pioglitazone Fixed-Dose Combination in Adults with Type 2 Diabetes Mellitus in India: PRO-3 StudyJournal of Diabetology · 2026
5. Dapagliflozin & pioglitazone combination therapy in T2DM with or without MASLD - a systematic review and meta-analysis: PRO-2 studyFrontiers in Clinical Diabetes and Healthcare · 2026
6. Semaglutide Injection Once‐Weekly for Weight Management in Adults: Results From A Randomized Phase III , Active‐Controlled StudyDiabetes Obesity and Metabolism · 2026
7. Semaglutide Injection in Indian Patients With Type 2 Diabetes Mellitus: A Randomised, Phase III , Active‐Controlled StudyDiabetes Obesity and Metabolism · 2026
8. Association of Time in Range with Glycemic Control Indicators in Indian Adults with Diabetes: A Retrospective Continuous Glucose Monitoring StudyJournal of Diabetology · 2026
9. Efficacy and Safety of Semaglutide for Managing Antipsychotic-associated Weight Gain: A Systematic Review and Meta-analysisIndian Journal of Endocrinology and Metabolism · 2026
10. A to Z of Health: An Evidence-Based Narrative Review of Multivitamin-Multimineral and Nutraceutical SupplementationCureus · 2026
11. Implications of Acetylator Status and Therapeutic Drug Monitoring of Plasma Rifampicin and Isoniazid Concentrations among IndiansJournal of the Association of Physicians of India · 2026
12. Endocrine Society of India’s National White Paper on Endocrine Disrupting Chemicals – A Call for ActionIndian Journal of Endocrinology and Metabolism · 2026
13. A Prospective Multicentric Development and Validation Study of a Patient-Reported Experience Measures (PREMS) Tool to Assess Medication Administration Safety in Indian HospitalsIJQHC Communications · 2026
14. International expert consensus on thermal ablation for benign thyroid nodules (2025 Edition)International Journal of Surgery · 2026
15. Optimizing Continuous Glucose Monitoring Adoption in India: From Current Challenges to Future SolutionsDiabetes Therapy · 2026
16. The Current Landscape of Nanopaclitaxel Formulations and the Benefits of Polymeric Micellar Paclitaxel in Solid TumorsIndian Journal of Medical and Paediatric Oncology · 2026
17. Inhaled Insulin Decoded: Dispelling Myths and Presenting Clinical EvidenceCureus · 2025
18. Glycemic control, weight-loss effects, and safety of cotadutide in individuals with type 2 diabetes: A systematic review and meta-analysisWorld Journal of Diabetes · 2025
19. Establishing a biomedical and health research unit in hospital setting: Overcoming barriers to translational research in India – A case studyPerspectives in Clinical Research · 2025
20. Epicardial adipose tissue in type 1 diabetes mellitus: a systematic review and meta-analysisThe Egyptian Heart Journal · 2025